mRNA technology helped propel the development of some of the most successful drugs in pharma history — notably, the Comirnaty COVID-19 from Pfizer generated almost $56 billion in 2022 while Moderna’s Spikevax vaccine raked in $18.4 billion. But with demand for COVID-19 vaccines cooling, drug developers are aiming to extend the dominion of mRNA technology…
30 promising biotech startups: Scatter plot
The preceding visual representation of the biotech startups of 2023 are grouped — clustered — according to their focus areas. Each cluster color corresponds to a specific domain: Orange for advanced molecular techniques (Cluster 0). Blue for cell and gene therapies (Cluster 1). Green for AI-driven drug discovery (Cluster 2). Red for epigenetics and genomic…